Aytu BioScience Announces Record Fiscal Q2 2021 Net Revenue of $15.1 Million, an Increase of 377% Year-Over-Year

Stock Information for Aytu BioPharma Inc.

Loading

Please wait while we load your information from QuoteMedia.